- Home
- GNLN vs CRIS Comparison
GNLN vs CRIS Comparison
Compare GNLN & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLN | CRIS |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 12.9M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GNLN | CRIS |
|---|---|---|
| Price | $1.44 | $0.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 220.2K | ★ 1.2M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,653,000.00 | ★ $11,650,000.00 |
| Revenue This Year | $1,541.21 | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $1.30 | $0.77 |
| 52 Week High | $1,200.03 | $3.57 |
Technical Indicators
Market Signals| Indicator | GNLN | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 45.16 |
| Support Level | $1.30 | $0.87 |
| Resistance Level | $1.80 | $0.96 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 45.99 | 61.01 |
Price Performance
Historical ComparisonAbout GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.